SLC35A5 Gene - Solute Carrier Family 35 Member A5

Comprehensive genomic and proteomic information for SLC35A5, a member of the solute carrier family 35, with implications in nucleotide sugar transport and potential roles in disease.

Gene Information Card

Symbol SLC35A5
Full Name solute carrier family 35 member A5
Gene Type gene with protein product
Chromosomal Location 3q13.2
NCBI Gene ID 55032 ncbi.nlm.nih.gov/gene/55032
Ensembl ID ENSG00000138459
UniProt ID Q9BS91
OMIM ID 620298
HGNC ID HGNC:20792
Aliases FLJ20730

Description

SLC35A5 encodes a member of the solute carrier family 35 (SLC35), which are nucleotide sugar transporters localized to the Golgi apparatus and endoplasmic reticulum. These transporters are essential for glycosylation processes by importing nucleotide sugars into the lumen of these organelles. SLC35A5 is predicted to be a multi-pass membrane protein with 10 transmembrane domains. It is widely expressed in various tissues, with higher expression in the thyroid, adrenal gland, and salivary gland. The protein may play a role in the transport of UDP-glucuronic acid and other nucleotide sugars, contributing to the synthesis of glycosaminoglycans and glycoproteins. Mutations in SLC35A5 have been associated with intellectual disability and other neurodevelopmental disorders, suggesting its importance in normal development.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual disability Loss-of-function mutations impair nucleotide sugar transport, affecting glycosylation in neurons. ClinVar and literature reports
Neurodevelopmental disorder with speech delay and dysmorphic facies Biallelic mutations lead to reduced protein function, disrupting glycoprotein processing in the brain. OMIM and case studies

Expression Profile

Tissue Expression
Tissue nTPM level
Thyroid 20.1 High
Adrenal gland 15.3 High
Salivary gland 12.8 High
Kidney 8.2 Medium
Liver 6.5 Medium
Brain 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 12.5 Moderate expression
HeLa 9.8 Moderate expression
HepG2 7.3 Low expression
K562 5.6 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.679C>T (p.Arg227*) Nonsense Rare Loss of function
c.1042G>A (p.Gly348Arg) Missense Rare Likely loss of function
c.1255delC (p.Leu419Trpfs*13) Frameshift Rare Loss of function
Mutation functional classification

Loss of Function (LOF)

Most pathogenic mutations are loss-of-function, leading to reduced or absent protein activity.

Gain of Function (GOF)

No evidence of gain-of-function mutations.

Dominant Negative (DN)

No evidence of dominant-negative effects.

Gene Ontology (GO)

• nucleotide-sugar transmembrane transporter activity • Golgi membrane
• integral component of membrane • transport

Pathways

• Nucleotide sugar transport
• Glycosylation

Protein Summary

The SLC35A5 protein is a putative nucleotide sugar transporter with 10 transmembrane domains. It is localized to the Golgi apparatus and is involved in the transport of nucleotide sugars, such as UDP-glucuronic acid, into the Golgi lumen for glycosylation reactions. The protein is widely expressed, with high levels in thyroid, adrenal, and salivary glands. Mutations in SLC35A5 are associated with neurodevelopmental disorders, indicating its critical role in brain development.

Related Products

Product name Cat.No. Species Gene ID
SLC35A5 Knockout HEK293 Cell Line EDC08375 Human 55032 Details Get a Quote
SLC35A5 Knockout HCT 116 Cell Line EDJ-KQ46038 Human 55032 Details Get a Quote
SLC35A5 Knockout HeLa Cell Line EDJ-KQ46039 Human 55032 Details Get a Quote
SLC35A5 Knockout A-549 Cell Line EDJ-KQ44818 Human 55032 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: